11 Matching Annotations
  1. Last 7 days
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Cemiplimab in locally advanced or metastatic secondary angiosarcomas (CEMangio): A phase II clinical trial and biomarker analyses
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12402795/
  3. Jun 2025
  4. 52.53.155.43 52.53.155.43
    PDF-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/22f68322b948f74711c059b254f94e963af26ed4/PDF-html.html
  5. Apr 2025
  6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11964177/
  7. Feb 2025
  8. aacrjournals.org aacrjournals.org
    Safety and efficacy of irradiation boost based on 18F-FET-PET in patients with newly diagnosed glioblastoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/clincancerres/article/28/14/3011/706875/Safety-and-Efficacy-of-Irradiation-Boost-Based-on
  9. Apr 2024
  10. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Phase 2 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10982638/
  11. Feb 2024
  12. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10524118/
  13. Dec 2023
  14. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase 1b Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10722139/
  15. 52.53.155.43 52.53.155.43
    ccr-23-0229-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/ff14fa8c7ad9abea8294fa337473afc457723345/ccr-23-0229-html.html
  16. Jan 2023
  17. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9377723/
  18. Aug 2022
  19. 52.53.155.43 52.53.155.43
    ccr-22-0171-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/975ed7699dc7d65ad528cb06c61b931c16326360/3011-html.html
  20. Jun 2022
  21. 52.53.155.43 52.53.155.43
    ccr-22-0171-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/975ed7699dc7d65ad528cb06c61b931c16326360/3011-html.html